Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2020 May 21;10:8454. doi: 10.1038/s41598-020-65199-3

Egg oil from Portunus trituberculatus alleviated obesity and regulated gut microbiota in mice

Shiwei Hu 1,✉, Huicheng Yang 2,✉, Xiang Gao 3, Shijie Li 1, Wei Jiang 1, Yu Liu 1
PMCID: PMC7242455  PMID: 32439940

Abstract

Egg oil from Portunus trituberculatus (Pt-egg oil) can overcome insulin resistance resulting from abundant bioactive lipids. However, its effects on obesity and gut microbiota were unclear. Here, we evaluated whether Pt-egg oil could improve obesity and gut microbiota or not in high-fat diet feeding mice. Results exhibited that Pt-egg oil markedly reduced body weight and adipose weight gain, improved lipid accumulation and circulatory cytokines, inhibited epididymal adipose cell size. Moreover, Pt-egg oil modified gut microbiota, involving decreases in the ratio of Firmicutes to Bacteroidetes, Proteobacteria, Actinobacteria, and increase in Verrucomicrobia phylum. Pt-egg oil reduced serum and fecal lipopolysaccharide (LPS) levels and down-regulated Toll-like receptor 4 pathway in both epididymal adipose and liver tissues. Meanwhile, Pt-egg oil increased short chain fatty acids and up-regulated of G-protein-coupled receptors in both epididymal adipose and liver tissues. These suggest that Pt-egg oil could be alternative food supplement for the prophylactic effects on anti-obesity and improvement in human gut health.

Subject terms: Obesity, Epidemiology

Introduction

Obesity is a serious public health problem resulting from the high incidence. It was reported that more than 1.9 billion adults were over weight, of which the obese people were over 650 million in 20161. The excess accumulation of body fat mass in obese people leads to numerous health problems and also increases the risks of series of disorders, such as type 2 diabetes, insulin resistance, hyperlipemia, and even cancer2. Therefore, how to prevent obesity has become a major challenge for modern societies. In the complex of factors to obesity development, gut microbiota is implicated as a master factor of nutrients uptake, energy metabolism, chronic inflammation, and other metabolic disorders3. Over the past decades, more and more researches confirm that gut microbiota contributes towards host metabolic homeostasis. Once the gut microbiota homeostasis is changed, many physiological disorders occur, including obesity and its complications4. For example, germ-free mice do not increase significantly in body weight even feeding high-fat diet (HFD), but showed remarkabe body weight gain when treated with fecal transplantation form obese animals5. It is reported that obesity is related with a high ratio of Firmicutes to Bacteroidetes (F/B) at the Phylum level6, but other paper showed that obesity is not significant related with the Firmicutes and Bacteroidetes7, implying that other factors may affect obesity. Perennial dysbacteriosis directly cause the physiological diseases by such secondary metabolites, especially lipopolysaccharide (LPS) and short chain fatty acids (SCFAs)8. As the primum movens, LPS can bind to Toll-like receptor 4 (TLR4) and subsequently activate its downstream gene, CD149. LPS/CD14 pathway lowers insulin sensitivity and promotes obesity10. Withal, SCFAs regulate metabolic pathways through binding and activating orphan G protein-coupled receptors (GPRs)11. Therefore, gut microbiota directly administers obesity and its related disorders.

Portunus trituberculatus is one kind of swimming crab, which is widely distributed in the Western Pacific coast. Profiting from its high nutritional value and great productions, Portunus trituberculatus has been a significant economic marine product, more than 600,000 tons in China in 201712. Current studies of Portunus trituberculatus are mainly involved in gene sequence analysis or aquiculture, but little papers involved in processing or utilization13. Our current study revealed that egg oil isolated from Portunus trituberculatus (Pt-egg oil) contained abundant phospholipids and triglyceride, which combined with a mass of eicosapentaenoic acid and docosahexaenoic acid14. Pt-egg oil remarkably reduced blood glucose and serum insulin levels in HFD-fed mice14. However, it is still unclear the influences of Pt-egg oil on obesity and the regulation of gut bacteria. Here, we investigated the effects of Pt-egg oil on anti-obesity and gut microbiota in HFD-fed mice, and clarify its mechanism on alleviation of obesity through regulation of microbial community and secondary metabolites.

Results

Pt-egg oil alleviated obesity

Referring to our previous study, at the last experiment of feeding, the mice showed a 27.68% decrease in body weight gain in Pt-egg oil mice compared with that in HFD group. However, though the food intake in each mouse is much lower in HFD-feeding mice than control animals, there were significant increases in energy intake per unit weight per week in HFD, and Pt-egg oil groups compared with that in control group (P  <  0.05). As compared with the control group, the HFD group displayed an evidently higher adipose weight (P  <  0.01), including perirenal adipose, epididymal adipose, and abdominal subcutaneous adipose. After 16 weeks of treatment with Pt-egg oil, the three aforementioned adipose weights were all significantly decreased in HFD-feeding mice (P  <  0.05, P  <  0.01). In addition, Fig. 1A,B showed that HFD caused remarkable increase in epididymal adipose cell size (P  <  0.01). When treated with Pt-egg oil, dramatic decrease in epididymal adipose cell size was observed in HFD-feeding animals (P  <  0.01). These results indicate that Pt-egg oil exhibits marked antiobese effect.

Figure 1.

Figure 1

Open in a new tab

Effects of Pt-egg oil on the histology of adipose and liver tissues using H&E staining (n = 10). The adipose cell size and hepatic lipids area were measured by CaseViewer 2.0, and the size or area of the control was defined as 1. ##P < 0.01 vs control; **P < 0.01 vs HFD.

Pt-egg oil reduced hepatic lipids

As shown in Table 1, compared with control group, hepatic weight was significantly elevated in HFD-induced obese mice (P  <  0.01). Pt-egg oil markedly inhibited the elevation of hepatic weight by 28.34%. These changes were accompanied with the significant decreases in TG content in the liver of Pt-egg oil-treated mice (P  <  0.01), through there was no significant difference in hepatic TC content between HFD mice and Pt-egg oil animals. These indicate that Pt-egg oil can significantly decrease lipids accumulation in the liver of obese mice.

Table 1.

Effect of Pt-egg oil on body or serum parameters in HFD mice.

Control HFD Pt-egg oil
Body weight gain (g) 11.46 ± 0.82 23.99 ± 1.26## 17.35 ± 0.87**
Food intake (g/w) 28.13 ± 1.55 23.18 ± 1.74# 22.72 ± 1.81#
Energy intake (kcal/w) 115.1 ± 5.7 152.3 ± 8.1# 149.3 ± 8.6#
Perirenal adipose weight (g) 0.17 ± 0.01 0.51 ± 0.05## 0.31 ± 0.03**
Epididymal adipose weight (g) 0.54 ± 0.07 1.92 ± 0.14## 1.10 ± 0.19**
Abdominal subcutaneous adipose weight (g) 0.17 ± 0.01 0.83 ± 0.10## 0.59 ± 0.07*
Hepatic weight (g) 1.09 ± 0.10 1.87 ± 0.16# 1.34 ± 0.18*
Serum TC (mmol/L) 2.54 ± 0.16 4.56 ± 0.37## 3.38 ± 0.14*
Serum TG (mmol/L) 0.80 ± 0.07 1.35 ± 0.19## 0.82 ± 0.09**
Serum HDL-c (mmol/L) 3.41 ± 0.30 2.57 ± 0.24## 3.66 ± 0.34**
Serum LDL-c (mmol/L) 0.56 ± 0.06 1.73 ± 0.09## 0.95 ± 0.08**
Hepatic TC (mg/g) 3.24 ± 0.28 4.05 ± 0.27# 3.77 ± 0.12
Hepatic TG (mg/g) 22.84 ± 1.93 35.40 ± 2.46## 19.06 ± 1.88**
Serum leptin (ng/mL) 0.20 ± 0.03 0.37 ± 0.03## 0.22 ± 0.02**
Serum adiponectin (µg/mL) 0.23 ± 0.01 0.13 ± 0.01## 0.19 ± 0.01*
Serum resistin (ng/mL) 5.96 ± 0.47 12.65 ± 1.06## 7.83 ± 0.64**
Serum TNF-α (pg/mL) 33.91 ± 2.38 70.10 ± 3.77## 47.31 ± 3.81**
Open in a new tab

Data are shown as mean ± S.D (n = 10/group). Multiple comparisons were done using one way ANOVA. #P < 0.05, ##P < 0.01 vs control; *P < 0.05, **P < 0.01 vs HFD.

Pt-egg oil inhibited hyperlipemia

Obesity individual is observed with the abnormal serum lipids levels. Pt-egg oil treatment remarkably reduced serum TC and TG levels in obese mice (P  <  0.01). Moreover, serum HDL-c was remarkably increased in Pt-egg oil group compared with HFD group (P  <  0.01), while LDL-c decreased (P  <  0.01). These indicate that Pt-egg oil can significantly inhibit hyperlipemia in obese mice.

Pt-egg oil regulated serum cytokines

Cytokines are closely related to obesity, such as resistin, leptin, adiponectin, and TNF-α. The data in these experiments showed that HFD obviously increased serum leptin, resistin, and TNF-α levels in mice (P  <  0.01), and reduced serum adiponectin level (P  <  0.01). When treated with Pt-egg oil, obese mice exhibited 40.54%, 38.10%, and 32.51% decreases in serum leptin, resistin, and TNF-α levels, and 46.15% increase in serum adiponectin level, respectively. These indicate that Pt-egg oil can regulate circulatory cytokines.

Pt-egg oil restored gut microbiota dysbiosis

Gut microbiota dysbiosis contributes positively to obesity. Figure 2A showed the data of Venn diagram analysis, and three groups showed the own distinct OTUs. PCA score plot showed an oberious different microbiota distribution between all experimental groups (Fig. 2B,C). Moreover, gut microbiota at the Phylum was significantly different (Fig. 2D). F/B ratio was statistically increased in HFD group compared with control group, which was significantly reduced in Pt-egg oil-treated animals compared with obese mice. Moreover, Pt-egg oil decreased Proteobacteria, while increased Verrucomicrobia. In addition, the abundance of Actinobacteria in Pt-egg oil-treated mice was remarkably decreased compared with obese mice.

Figure 2.

Figure 2

Open in a new tab

Effects of Pt-egg oil on the composition of the gut microbiota in HFD mice (n = 4). (A) Venn diagrams showing the unique and shared OTUs in the gut microbiota among three groups; (B) the weighted version of UniFrac-based Principal Component Analysis (PCA); (C) multivariate analysis of variance from matrix scores; (D) bacteria taxonomic profiling in the phylum level of intestinal bacteria from different groups. Univariate differential abundance of OTUs at the Phylum level was tested by incorporating Fisher’s exact test and the false discovery rate (FDR) among control, HFD, and Pt-egg oil groups and between mouse genotypes. P values were corrected with the Benjamini-Hochberg method to correct for the false discovery rate across multiple comparisons, which were generated using Metastats and considered significance at P  <  0.05. ##P < 0.01 vs control; *P < 0.05, **P < 0.01 vs HFD.

Figure 3 showed that 48 genus exhibited remarkably different abundances in HFD mice compared with control, and 41 genus different in Pt-egg oil mice compared with HFD, implying that Pt-egg oil may alleviate obesity through regulating bacterial subset. Pt-egg oil reduced the numbers of Ruminiclostridium_5, Ruminiclostridium, Ruminococcaceae_UCG-013, Anaerotruncus, Oscillibacter, Faecalibaculum, norank_f_Erysipelotrichaceae, (all belonging to Firmicutes), Helicobacter, (belonging to Proteobacteria) unclasslfied_Coriobacteriaceae and Coriobacteriaceae_UCG-002, (belonging to Actinobacteria), Bifidobactenium, and Desulfovibrio compared with obese mice. While the relative abundances of Rikenellaceae_RC9_gut_group, Parabacteroides, and Paraprevotella (belonging to Bacteroidetes), Lactobacillus, Marvinbryantia, Adlercreutzia, Candidatus_Saccharimonas, Family_XIII_AD3011_group, Asllobaculum, and Romboutsia were increased in Pt-egg oil mice. In addition, the abundances of the SCFAs-producing microbiota Lachnospiraceae_NK4A136_group, norank_f_Lachnospiraceae, Ruminiclostridium_9, Prevotellaceae_UCG-001, Butyricimonas, Alloprevotella, Clostridium_sensu_stricto_1, Allobaculum, and Bacteroides were increased in HFD-fed mice supplemented with Pt-egg oil. Notably, unclassified_f_Ruminococcaceae and Akkermansia (belonging to Verrucomicrobia), were enriched by Pt-egg oil treatment in obese mice.

Figure 3.

Figure 3

Open in a new tab

Effects of Pt-egg oil on gut microbiota at the genus level (n = 4). Heatmap indicats relative contribution of the top 50 dominat genera in each sample (A) and different groups (B). The heatmap is colour-coded based on row Z-scores.

LEfSe analysis (LDA score log 10 > 4) was conducted to identify specific phylotypes which were changed by Pt-egg oil treatment. Firmicutes was increased in HFD mice, mainly including Erysipelotrichia and unclassified_p_Firmicutes at class level (Fig. 4A). HFD also caused an increase in Epsilonproteobacteria at class level, belonging to Proteobacteria (Fig. 4A). HFD feeding decreased the levels of Bacteroidetes, in which Bacteroidia was the dominant strain at class level (Fig. 4A). Supplementation with Pt-egg oil significantly reduced Epsilonproteobacteria abundance, and increased Bacteroidia at class level (Fig. 4B), but no significant difference in Firmicutes Phylum.

Figure 4.

Figure 4

Open in a new tab

Effects of Pt-egg oil on the bacterial taxa in HFD-fed mice (n = 4/group). (A,B) show different taxa between the control and HFD groups, HFD and Pt-egg oil groups, respectively.

Pt-egg oil regulated secondary metabolites of gut microbiota

Obesity is regulated by gut microbiota through the secondary metabolites, including LPS and SCFAs. As shown in Fig. 5A,B, HFD feeding caused obvious increases in LPS concentrations in serum and in feces (P  <  0.01). Pt-egg oil significantly decreased serum and fecal LPS concentrations by 50.16% and 31.19%, respectively. Fecal and serum acetate, propionate, and butyrate contents were all remarkably reduced in obese mice compared with control group (Fig. 5C–H, P  <  0.01). Interestingly, the three fecal SCFAs were significantly increased in Pt-egg oil-receiving mice by 89.56%, 1.13 fold, and 74.60%, respectively. Moreover, Serum acetate and butyrate concentrations were remarkably increased by 39.72% and 69.40% in Pt-egg oil group compared with HFD group. However, there is not significant difference in serum propionate level between Pt-egg oil group compared with HFD group.

Figure 5.

Figure 5

Open in a new tab

Effects of Pt-egg oil on the secondary metabolites of gut microbiota in HFD mice (n = 10/group). (A) serum LPS concentration; (B) fecal LPS concentration; (C) fecal acetate concentration; (D) fecal propionate concentration; (E) fecal butyrate concentration; (F) serum acetate concentration; (G) serum propionate concentration; (H) serum butyrate concentration. #P < 0.05, ##P < 0.01 vs control; *P < 0.05, **P < 0.01 vs HFD.

Pt-egg oil down-regulated LPS-dependent pathway and up-regulated SCFAs-dependent pathway

LPS and SCFAs affect obesity through spurring specific cascades, including LPS-dependent TLR4 pathway and SCFAs-dependent GPRs pathway in both adipose and the liver tissues. Table 2 showed that HFD feeding elevated TLR4 and CD14 mRNA relative expression, while Pt-egg oil down-regulated the levels of TLR4 and CD14 mRNA in adipose tissues of obese mice (P  <  0.05, P  <  0.01). Moreover, HFD induced strong decreases in GPR41 and GPR43 mRNA expression in adipose tissues, and Pt-egg oil significantly reversed the reductions (P  <  0.01). In addition, Pt-egg oil markedly lowered TLR4 and CD14 mRNA expression and increased GPR41 and GPR43 mRNA expression in the liver of obese mice (P  <  0.05, P  <  0.01).

Table 2.

Effect of Pt-egg oil on TLR4, CD14, GPR41, and GPR43 mRNA expression in epididymal adipose and liver tissues of HFD mice.

Gene Control HFD Pt-egg oil
Epididymal adipose tissues TLR4 1.00 ± 0.11 2.09 ± 0.18## 1.44 ± 0.15*
CD14 1.00 ± 0.19 3.06 ± 0.33## 1.81 ± 0.20**
GPR41 1.00 ± 0.14 0.35 ± 0.06## 0.73 ± 0.09**
GPR43 1.00 ± 0.09 0.42 ± 0.04## 0.87 ± 0.08**
Liver tissues TLR4 1.00 ± 0.15 2.47 ± 0.18## 1.93 ± 0.15*
CD14 1.00 ± 0.17 2.51 ± 0.24## 1.99 ± 0.18*
GPR41 1.00 ± 0.20 0.57 ± 0.05## 0.71 ± 0.08*
GPR43 1.00 ± 0.13 0.62 ± 0.06## 0.96 ± 0.07**
Open in a new tab

Data are shown as mean ± S.D (n = 10/group). Multiple comparisons were done using one way ANOVA. ##P < 0.01 vs control; *P < 0.05, **P < 0.01 vs HFD.

Discussion

Gut microbiota has been considered as an key environmental factor in the development of obesity15. In this study, the effects of Pt-egg oil on antiobesity and regulation of gut microbiota were investigated. The data showed that Pt-egg oil reduced body and adipose weight, serum and hepatic lipids, and epididymal adipose cell size, which suggesting the significant antiobese effects of Pt-egg oil. Gut microbiota analysis showed that Pt-egg oil prevented the loss of Bacteroidetes and Verrucomicrobia and restrained the increase of Firmicutes, Proteobacteria, and Actinobacteria in obese mice. This study also demonstrated that Pt-egg oil mediated LPS and SCFAs production.

Numerous studies have shown that gut microbiota of obese individual is characterized by an abnormal gut microbiota composition16,17. We measured community structures of each group by PCA, and it was clear separation between the three group. These suggested that Pt-egg oil could help to shape gut microbiota community through natural selection and competing18. Some contradictory conclusions on the change of F/B ratio were shown in obese individual. For example, Cui et al. reported that an increase F/B ratio developed obesity in HFD mice, and fish and frill oil mixture alleviated the ratio19. However, other papers showed a low F/B ratio in obese mice5,20. In the present study, HFD feeding elevated F/B ratio in mice, which was restored by Pt-egg oil treatment. At the genus level, Pt-egg oil reduced Ruminiclostridium_5, Ruminiclostridium, Ruminococcaceae_UCG-013, Anaerotruncus, Oscillibacter, Faecalibaculum, norank_f_Erysipelotrichaceae, which are all belonging to Firmicutes, and increased Prevotellaceae_UCG-001, Rikenellaceae_RC9_gut_group, Parabacteroides, and Paraprevotella, belonging to Bacteroidetes. Previous studies indicated that Proteobacteria and Actinobacteria were positively correlated with obesity, while Verrucomicrobia was negatively correlated with obesity21–23. Pt-egg oil treatment reduced Proteobacteria and Actinobacteria, and increased Verrucomicrobia at the Phylum level. Further, Helicobacter, belonging to Proteobacteria, unclasslfied_Coriobacteriaceae and Coriobacteriaceae_UCG-002, belonging to Actinobacteria, were lowered by Pt-egg oil. The numbers of unclassified_f_Ruminococcaceae and Akkermansia, belonging to the Phylum Verrucomicrobia, were also elevated in obese mice when treated with Pt-egg oil. Noticeably, the Gram-negative Desulfovibrio genus was significantly reduced in Pt-egg oil-treated mice, which is responsible for inflammation and obesity resulting from lipid A structures of LPS24. Lactobacillus and Bacteroides, the beneficial intestinal bacteria, were also promoted by Pt-egg oil, which is proved to positively relate to intestinal integrity, glucose tolerance or attenuated obesity25,26. In addition, Pt-egg oil reversed HFD-decreased Bacteroidia at class level, which is negatively correlated with obesity. Meanwhile, Erysipelotrichia and unclassified_p_Firmicutes, belonging to Firmicutes, was reduced by Pt-egg oil, which could positively stimulate obesity and hyperlipemia27. Similar results can also be found in studies on other marine bioactive lipids28,29. These indicate that Pt-egg oil can alleviate obesity by directly modulating gut microbiota.

Special microbiota can produce SCFAs, including Bacteroides, Lactobacillus, Bifidobacterium, Prevotella, Lachnospiraceae, Butyricimonas, Alloprevotella, Clostridium, Allobaculum etc.30–32. Our results showed that Pt-egg oil promoted the abundance of the SCFAs-producing microbiota Lachnospiraceae_NK4A136_group, norank_f_Lachnospiraceae, Prevotellaceae_UCG-001, Ruminiclostridium_9, Butyricimonas, Alloprevotella, Clostridium_sensu_stricto_1, Allobaculum, and Bacteroides, but lowered Bifidobacterium. After transporting into blood, SCFAs can be taken up by body tissues and subsequently act as substrates and signal melecules33. Acetate could promote cholesterol synthesis, and propionate and butyrate could modulate lipid/cholesterol metabolisms34. Pt-egg oil significantly enhanced fecal acetate, propionate, and butyrate contents in obese mice, and also increased serum acetate and butyrate concentrations. These changes may be associated with the improvement in many factors in Pt-egg oil-treated mice, such as regulation of gut microbiota composition, decrease in body weight gain, and others35. As SCFAs receptors, GPR41 and GPR43 take part in such metabolic pathways, including lipolysis and lipogenesis36. Many studies proved that the increases in GPR41 and GPR43 expression could mitigate serum lipids and obesity37,38. In this study, Pt-egg oil increased SCFAs and GPR41 and GPR43 mRNA expression. Pt-egg oil-treated mice also showed significant improvement on serum and hepatic lipids levels, body weight gain, adipocyte size, and adipocytokines. These demonstrate that Pt-egg oil-inducted SCFAs generation by regulating special gut flora positively contributes to antiobese effects in mice.

LPS can provoke obesity, inflammation, and even diabetes with the most potent capability39. Significantly, the abundances of Proteobacteria Phylum, Desulfovibrio and Enterorhabdus, LPS producing bacteria, were reduced by Pt-egg oil treatment. And this regulation was accompanied with decreases in serum and fecal LPS concentrations. Thus, we suggest that the inhibition of pathogenic LPS-producing bacteria by Pt-egg oil might result in a decrease of the decrease of the LPS load into the systemic circulation, and may revealed that the antiobese effects of Pt-egg oil is, in part, responsible for the dramatically reduction in LPS. Previous study has shown that LPS could induce intestinal barrier integrity impared40. Pt-egg oil stimulated the elevations in intestinal barrier protectors abundance, such as Lachnospiraceae_NK4A136_group and norank_f_Lachnospiraceae41. In addition, LPS reduction has been repeatedly shown to improve obesity and obesity-related cytokines42, and in this study, Pt-egg oil decreased LPS concentrations which were associated with enhanced adiponectin, and lowered leptin, resistin, and TNF-α. TLR4/CD14 pathway triggered by LPS is the primary mechanism linking gut bacteria to alleviate obesity43. In HFD-fed TLR4-deficient mice, the epididymal adipose weight and blood LPS level were only 69% and 18% of HFD mice, respectively44. In the present study, Pt-egg oil inhibited the elevation of TLR4 and CD14 gene mRNA expression in adipose and liver tissues, which is conjuncted with the regulation of gut microbiota, declines in LPS levels, and decreases in body and fat weight. All of these demonstrate that Pt-egg oil alleviates obesity by improving gut microbiota and LPS.

In summary, this paper demonstrated that Pt-egg oil alleviated HFD-induced obesity and improved lipids metabolism in mice. These were directly related with the modulation of gut microbiota community. Pt-egg oil-regulated specific bacteria could improve body weight and lipids metabolism by down-regulation of LPS/TLR4 pathway and up-regulation of SCFAs/GPRs signaling. In short, it suggested that Pt-egg oil may be an alternative food supplement in alleviating obesity and improving other intestinal diseases.

Materials and methods

Statement

All methods in these experiments were conducted according to the relevant guidelines and regulations of Qingdao University. Moreover, the animals’ experimental protocols were approved by the ethical committee for experimental animal care at Qingdao University.

Preparation of Pt-egg oil

Tongqu Aquatic Food Company (Zhoushan, Zhejiang, China) provided Portunus trituberculatus eggs. Pt-egg oil was prepared according to our previous study14. Pt-egg oil contained 52.05% phospholipids, 8.61% free fatty acids (containing 23.84% saturated fatty acids and 76.16% unsaturated fatty acids, especially 33.23% eicosapentaenoic acid and docosahexaenoic acid), 32.38% triglyceride, 4.79% total cholesterol, and 971.79 μg/g astaxanthin14.

Animal experiments

C57BL/6J mice (male, 16-18 g, 4-5 weeks) were from Vital River Laboratory Animal Center (Beijing, China; licensed ID SCXK2014-0004). They were fed in a 12:12 h light-dark condition at 22–24 °C in normal cages. The mice were randomized into three groups (10 per group): control group (fed with normal chow diet: 74% corn starch, 16% casein, and 10% corn oil based on weight, 4.09 kcal/g), high fat diet (HFD)-feeding group (fed with HFD: 29% corn starch, 16% casein, 10% corn oil, and 45% lard based on weight, 6.57 kcal/g), and Pt-egg oil group (administrated with HFD and 600 mg/kg Pt-egg oil intragastrically). After 16 weeks treatment, faeces were collected form each mouse feeding in metabolism cages. The animals were sacrificed after 12 h fasting and serum was collected to measure serum lipids and adipokines contents. The liver and epididymal adipose tissues were separated rapidly for hematoxylin and eosin (H&E) stain or measurement of hepatic lipids.

Serum and hepatic lipids analysis

Serum TC, TG, HDL-c, and LDL-c concentrations were detect by commercial kits (Jiancheng, Najing, Jiangsu, China).

Hepatic TG and TC levels measured by the same kits as used in serum analysis after the lipids in liver extracted by the method of Folch et al.

Adipokines detection

Serum adiponectin, resistin, leptin, and tumor necrosis factor-α (TNF-α) levels were detected by the ELISA kits (Invitrogen, Carlsbad, CA, USA) according to the manufacture’s instructions.

H&E stain

H&E stainning was performed in epididymal adipose tissues after formalin, paraffin embedded, sectioned. Fat microscopic structures were photographed by a fluorescence microscope (Eclipse Ci, Nikon, Japan) and using CaseViewer 2.0 to get adipose cell size. The size in control group was defined as 1.

Serum and fecal LPS measurement

After diluted to 20% (v/v) with water, serum was heated to 70 °C to inactivate proteins. Serum LPS was measured by ELISA kit (Invitrogen, Carlsbad, CA, USA).

Faeces was homogenized in ice-cold Millipore H2O, and then centrifuged at 7,500 × g for 15 min. The supernatant fraction was heated to 70 °C to inactivate proteins. Fecal LPS was measured according to the aforementioned methods.

Serum and fecal SCFAs determination

Serum and fecal SCFAs levels were evaluated according to our previous study45.

Fecal DNA extraction

DNA (n = 4 per group) was extracted from feces by QIAamp DNA Stool Mini Kit (Qiagen, Dusseldorf, Germany).

Intestinal microflora analysis

PCR amplify, sequences analysis, taxonomic identification, alpha and beta diversities were all performed according to our previous stidies45,46.

Quantitative real time polymerase chain reaction (qRT-PCR) analysis. Total epididymal adipose and hepatic mRNA was isolated using a TRIzol reagent, and then reverse transcribed into cDNA. The expression levels of TLR4, CD14, GPR41, and GPR43 were analyzed as our previous study.46 β-actin was used as the control and mean expression level in control group was set as 1. The primers were as follow: TLR4 (F, 5′-TCAGAGCCGTTGGTGTATCTT-3′, R, 3′-AACTCTTCAGGGACGACTCC-5′), CD14 (F, 5′-TTGGCTTGTTGCTGTTGCTTC-3′, R,3′-TAGAGTTGTAGAACTTGGAGGCG-5′), GPR41 (F, 5′-CTGCTCCTGCTCCTCCTC-3′, R, 3′-CCAGGCGACTGTAGCAGT-5′), GPR43 (F, 5′-TTCTTACTGGGCTCCCTGCC-3′, R, 3′-TACCAGCGGAAGTTGGATGC-5′), and β-actin (F, 5′-CAAGGCATTGCTGACAGGATG-3′, R,3′-GGTCGTCTACACCTAGTCGT-5′).

Statistical analysis

OTUs univariate differential value at Phylum level was tested according to Fisher’s test. P  <  0.05 is considered significance after Benjamini-Hochberg method correcting. Data are shown as mean ± S.D and statistically analyzed by SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). Difference between three groups is conducted by Student’s test and P  <  0.05 is considered significance.

Acknowledgements

The paper was funded by Public Projects of Zhejiang Province (LGN19D060001), National Natural Science Foundation of China (41806182), Natural Science Foundation of Shandong Province (ZR2019PC014), and China Postdoctoral Science Foundation (2019).

Author contributions

S. Hu, H. Yang and X. Gao designed and analyzed experiments. S. Hu and S. Li wrote the manuscript. W. Jiang and Y. Liu analyzed the data. S. Hu, W. Jiang and Y. Liu acquired funding. All authors discussed the results and commented on the manuscript.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Shiwei Hu, Email: hushiweihai@163.com.

Huicheng Yang, Email: huichengy@163.com.

References

  • 1.Duan M, et al. Polysaccharides from Laminaria japonica alleviated metabolic syndrome in BALB/c mice by normalizing the gut microbiota. Int J Biol Macromol. 2019;121:996–1004. doi: 10.1016/j.ijbiomac.2018.10.087. [DOI] [PubMed] [Google Scholar]
  • 2.Karczewski J, et al. Obesity and inflammation. Eur Cytokine Netw. 2018;29:83–94. doi: 10.1684/ecn.2018.0415. [DOI] [PubMed] [Google Scholar]
  • 3.Saad MJ, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology (Bethesda) 2016;31:283–293. doi: 10.1152/physiol.00041.2015. [DOI] [PubMed] [Google Scholar]
  • 4.Lee HC, Yu SC, Lo YC, Lin IH, Tung TH, Huang SY. A high linoleic acid diet exacerbates metabolic responses and gut microbiota dysbiosis in obese rats with diabetes mellitus. Food Funct. 2019;10:786–798. doi: 10.1039/c8fo02423e. [DOI] [PubMed] [Google Scholar]
  • 5.Zheng, J., et al. Chitin oligosaccharide modulates gut microbiota and attenuates high-fat-diet-induced metabolic syndrome in mice. Ma Drugs16, 10.3390/md16020066 (2018). [DOI] [PMC free article] [PubMed]
  • 6.Zhu W, Lin K, Li K, Deng X, Li C. Reshaped fecal gut microbiota composition by the intake of high molecular weight persimmon tannin in normal and high-cholesterol diet-fed rats. Food Func. 2018;9:541–551. doi: 10.1039/c7fo00995j. [DOI] [PubMed] [Google Scholar]
  • 7.Schwiertz A, et al. Microbiota and SCFA in line and overweight healthy subjects. Obesity (Silver Spring) 2010;18:190–195. doi: 10.1038/oby.2009.167. [DOI] [PubMed] [Google Scholar]
  • 8.Zhu Z, et al. Sulfated polysaccharide from sea cucumber and its depolymerized derivative prevent obesity in association with modification of gut microbiota in high-fat diet-fed mice. Mol Nutr Food Res. 2018;62:e1800446. doi: 10.1002/mnfr.201800446. [DOI] [PubMed] [Google Scholar]
  • 9.Le Sage F, Meilhac O, Gonthier MP. Porphyromonas gingivalis lipopolysaccharide induces pro-inflammatory adipokine secretion and oxidative stress by regulating Toll-like receptor-mediated signaling pathways and redox enzymes in adipocytes. Mol Cell Endocrinol. 2017;446:102–110. doi: 10.1016/j.mce.2017.02.022. [DOI] [PubMed] [Google Scholar]
  • 10.Cani PD, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–1772. doi: 10.2337/db06-1491. [DOI] [PubMed] [Google Scholar]
  • 11.Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K. Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Sci Rep. 2016;6:37589. doi: 10.1038/srep37589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lv J, Zhang L, Liu P, Li J. Transcriptomic variation of eyestalk reveals the genes and biological processes associated with molting in Portunus trituberculatus. Plos One. 2017;12:e0175315. doi: 10.1002/aorn.12603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ng’ambi JW, Li R, Mu C, Song W, Liu L, Wang C. Dietary administration of saponin stimulates growth of the swimming crab Portunus trituberculatus and enhances its resistance against Vibrio alginolyticus infection. Fish Shellfish Immunol. 2016;59:305–311. doi: 10.1016/j.fsi.2016.10.041. [DOI] [PubMed] [Google Scholar]
  • 14.Hu, S., Wang, J., Yan, X., Li, S., Jiang, W. & Liu, Y. Egg oil from Portunus trituberculatus improves insulin resistance through activation of insulin signaling in mice. Appl Physiol Nutr Metab, 10.1139/apnm-2018-0718 (2019). [DOI] [PubMed]
  • 15.Gérard P. Gut microbiota and obesity. Cell Mol Life Sci. 2016;73:147–162. doi: 10.1007/s00018-015-2061-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031. doi: 10.1038/nature05414. [DOI] [PubMed] [Google Scholar]
  • 17.Miele L, Giorgio V, Alberelli MA, De Candia E, Gasbarrini A, Grieco A. Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk. Curr Cardiol Rep. 2015;17:120. doi: 10.1007/s11886-015-0671-z. [DOI] [PubMed] [Google Scholar]
  • 18.Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH. The influence of diet on the gut microbiota. Pharmacol Res. 2013;69:52–60. doi: 10.1016/j.phrs.2012.10.020. [DOI] [PubMed] [Google Scholar]
  • 19.Cui C, et al. Modulation of the gut microbiota by the mixture of fish oil and krill oil in high-fat diet-induced obesity mice. Plos One. 2017;12:e0186216. doi: 10.1002/aorn.12603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yan H, Lu J, Wang Y, Gu W, Yang X, Yu J. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats. Phytomedicine. 2017;26:45–54. doi: 10.1016/j.phymed.2017.01.007. [DOI] [PubMed] [Google Scholar]
  • 21.Zhong Y, Nyman M, Fåk F. Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. Mol Nutr Food Res. 2015;59:2066–2076. doi: 10.1002/mnfr.201500187. [DOI] [PubMed] [Google Scholar]
  • 22.Jiao X, et al. Blueberry polyphenols extract as a potential prebiotic with anti-obesity effects on C57BL/6J mice by modulating the gut microbiota. J Nutr Biochem. 2019;64:88–100. doi: 10.1016/j.jnutbio.2018.07.008. [DOI] [PubMed] [Google Scholar]
  • 23.Liu Z, et al. The modulatory effect of infusions of green tea, oolong tea, and black tea on gut microbiota in high-fat-induced obese mice. Food Funct. 2016;7:4869–4879. doi: 10.1039/c6fo01439a. [DOI] [PubMed] [Google Scholar]
  • 24.Zhang Sun W, Augusto LA, Zhao L, Caroff M. Desulfovibrio desulfuricans isolates from the gut of a single individual: structural and biological lipid A characterization. FEBS Lett. 2015;589:165–171. doi: 10.1016/j.febslet.2014.11.042. [DOI] [PubMed] [Google Scholar]
  • 25.Koleva PT, Bridgman SL, Kozyrskyj AL. The infant gut microbiome: evidence for obesity risk and dietary intervention. Nutrients. 2015;7:2237–2260. doi: 10.3390/nu7042237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kim H, et al. Modulation of the intestinal microbiota is associated with lower plasma cholesterol and weight gain in hamsters fed chardonnay grape seed flour. J Agric Food Chem. 2015;63:1460–1467. doi: 10.1021/jf5026373. [DOI] [PubMed] [Google Scholar]
  • 27.Jung Y, et al. Effect of Kombucha on gut-microbiota in mouse having non-alcoholic fatty liver disease. Food Sci Biotechnol. 2018;28:261–267. doi: 10.1007/s10068-018-0433-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bidu C, et al. The transplantation of ω3 PUFA-altered gut microbiota of fat-1 mice to wild-type littermates prevents obesity and associated metabolic disorders. Diabetes. 2018;67:1512–1523. doi: 10.2337/db17-1488. [DOI] [PubMed] [Google Scholar]
  • 29.Li H, et al. Fish oil, lard and soybean oil differentially shape gut microbiota of middle-aged rats. Sci Rep. 2017;7:7738. doi: 10.1038/s41598-017-04862-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sivaprakasam S, Prasad PD, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther. 2016;164:144–151. doi: 10.1016/j.pharmthera.2016.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Org E, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol. 2017;18:70. doi: 10.1186/s13059-017-1194-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gao B, Wang R, Peng Y, Li X. Effects of a homogeneous polysaccharide from Sijunzi decoction on human intestinal microbes and short chain fatty acids in vitro. J Ethnopharmacol. 2018;224:465–473. doi: 10.1016/j.jep.2018.06.006. [DOI] [PubMed] [Google Scholar]
  • 33.Kuwahara A. Contributions of colonic short-chain fatty acid receptors in energy homeostasis. Front Endocrinol (Lausanne) 2014;5:144. doi: 10.3389/fendo.2014.00144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Venter, C. S., Vorster, H. H. & Cummings, J. H. Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol85, 549–553, https://PMID: 2159696 (1990). [PubMed]
  • 35.Trompette A, et al. Gut microbiota metabolism of dietary fiber influence s allergic airway disease and hematopoiesis. Nat Med. 2014;20:159–166. doi: 10.1038/nm.3444. [DOI] [PubMed] [Google Scholar]
  • 36.Besten GD, Eunen KV, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325–2340. doi: 10.1194/jlr.R036012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ang Z, Ding JL. GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative? Front Immunol. 2016;7:28. doi: 10.3389/fimmu.2016.00028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Li, T., Gao, J., Du, M. & Mao, X. Bovine α-lactalbumin hydrolysates ameliorate obesity-associated endotoxemia and inflammation in high-fat diet-fed mice through modulation of gut microbiota. Food Funct, 10.1039/c8fo01967c (2019). [DOI] [PubMed]
  • 39.Verotta L, et al. Fermented pomegranate wastes as sustainable source of ellagic acid: Antioxidant properties, anti-inflammatory action, and controlled release under simulated digestion conditions. Food Chem. 2018;246:129–136. doi: 10.1016/j.foodchem.2017.10.131. [DOI] [PubMed] [Google Scholar]
  • 40.Cani PD, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58:1091–1103. doi: 10.1136/gut.2008.165886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Mei X, et al. Insulin sensitivity-enhancing activity of phlorizin is associated with lipopolysaccharide decrease and gut microbiota changes in obese and type 2diabetes (db/db) mice. J Agric Food Chem. 2016;64:7502–7511. doi: 10.1021/acs.jafc.6b03474. [DOI] [PubMed] [Google Scholar]
  • 42.Hersoug LG, Møller P, Loft S. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity. Nutr Res Rev. 2018;31:153–163. doi: 10.1017/S0954422417000269. [DOI] [PubMed] [Google Scholar]
  • 43.Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. Plos One. 2012;7:e47713. doi: 10.1371/journal.pone.0047713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Folch, J., Lees, M. & Sloane-Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem226 497–509, https://PMID: 13428781 (1957). [PubMed]
  • 45.Hu S, Wang J, Wang J, Yang H, Yan X, Su L. Fucoidan from Acaudina molpadioides improves insulin resistance by altering gut microbiota dysfunction. J Funct Food. 2019;57:59–67. doi: 10.1039/C8FO02364F. [DOI] [Google Scholar]
  • 46.Hu S, et al. Anti-inflammation effects of fucosylated chondroitin sulphate from Acaudina molpadioides by altering gut microbiota in obese mice. Food Funct. 2019;10:1736–1746. doi: 10.1039/c8fo02364f. [DOI] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES